Physician profile
Bassem Srour
NPI 1851599179
$15,945.65
in general payments reported to CMS, 2019-2025
54 companies · $3,977 in 2025
The $3,977 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2020: $846 · 2021: $1,532 · 2022: $2,829 · 2023: $2,831 · 2024: $2,484 · 2025: $3,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,664 · Travel and Lodging: $548 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,663.74 |
| Travel and Lodging | $548.46 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,739.88 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $2,158.46 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Mylan Specialty L.P. | $1,442.82 | 2019-2024 | Yupelri, Yupelri |
| Regeneron Healthcare Solutions, INC. | $900.92 | 2020-2025 | Dupixent |
| Medical Device Business Services, INC. | $707.93 | 2025 | Monarch |
| Janssen Pharmaceuticals, INC | $631.36 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $604.97 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Genzyme Corporation | $455.20 | 2021-2025 | |
| Inspire Medical Systems, INC. | $429.72 | 2024-2025 | Inspire |
| Amgen INC. | $418.69 | 2022-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $412.80 | 2019-2025 | Xywav |
| Electromed, INC. | $407.55 | 2019-2025 | Smartvest |
| Abiomed | $318.54 | 2023-2024 | Impella |
| Shionogi INC | $310.31 | 2022-2025 | Fetroja |
| Grifols USA, LLC | $308.76 | 2019-2025 | Prolastin-C Liquid |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $272.81 | 2019-2024 | Opsumit |
| Harmony Biosciences LLC | $243.64 | 2020-2023 | Wakix |
| Penumbra, INC. | $239.32 | 2022-2023 | Indigo System |
| Viatris Specialty LLC | $237.70 | 2025 | Yupelri |
| United Therapeutics Corporation | $228.85 | 2020-2025 | Tyvaso, Tyvaso |
| Baxter Healthcare | $227.64 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $189.65 | 2020-2025 | Arikayce, Brinsupri |
| Sunovion Pharmaceuticals INC. | $156.84 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $137.42 | 2020-2025 | Glassia |
| Galvanize Therapeutics, INC | $135.58 | 2023 | Aliya System |
| Intuitive Surgical, INC. | $127.27 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $122.34 | 2021 | |
| Genentech USA, INC. | $114.39 | 2019-2022 | |
| Advanced Respiratory, INC | $102.98 | 2020-2021 | |
| Pfizer INC. | $96.72 | 2019-2025 | |
| Axsome Therapeutics, INC. | $88.41 | 2023-2025 | Sunosi |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Novartis Pharmaceuticals Corporation | $77.28 | 2019-2025 | |
| Lilly USA, LLC | $75.43 | 2025 | Zepbound |
| Ani Pharmaceuticals, INC. | $66.67 | 2024 | Purified Cortrophin Gel |
| Merck Sharp & Dohme LLC | $65.06 | 2021-2024 | Winrevair |
| Vapotherm INC | $59.44 | 2022 | |
| Philips North America LLC | $55.79 | 2021-2024 | (Ak6) Vest Therapy |
| Paratek Pharmaceuticals, INC. | $54.50 | 2022-2025 | Nuzyra |
| Bayer Healthcare Pharmaceuticals INC. | $50.90 | 2019-2023 | |
| Shire North American Group INC | $44.21 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $43.88 | 2021-2022 | |
| Inogen, INC. | $42.11 | 2023-2025 | Inogen One G3 Oxygen Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ceribell, INC. | $39.29 | 2024 | Pocket Eeg Device |
| Mallinckrodt Hospital Products INC. | $33.49 | 2020 | |
| Nabriva Therapeutics, Plc | $31.95 | 2020 | |
| Tactile Systems Technology INC | $26.21 | 2024 | Flexitouch Plus, Entre Plus |
| Pharming Healthcare, INC. | $23.99 | 2023 | Ruconest |
| Vifor Pharma, INC. | $21.37 | 2025 | Zemaira |
| Mayne Pharma Commercial LLC | $20.30 | 2021 | |
| Chiesi USA, INC. | $20.14 | 2025 | Kengreal, Cleviprex |
| Verona Pharma, INC. | $15.52 | 2025 | Ohtuvayre |
| Veran Medical Technologies, INC. | $15.27 | 2019 | |
| Gilead Sciences, INC. | $14.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassem Srour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.